A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients

Transplantation

Volumn 82, Issue 7, 2006, Pages 979-982

  Cervera, Carlos ^a   Marcos, María Angeles ^a   Linares, Laura ^a   Roig, Eulalia ^a   Benito, Natividad ^a   Pumarola, Tomás ^a   Moreno, Asunción ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Adult solid organ transplantation; Human herpesvirus 6 primary infection; Quantitative polymerase chain reaction

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; CHOLESTATIC HEPATITIS; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIMARY INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SEROLOGY; VIRUS LOAD;

COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; ROSEOLOVIRUS INFECTIONS; SPAIN; TIME FACTORS;

EID: 33749851028     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000229938.12722.ee     Document Type: Article

References (14)

1. Campadelli-Fiuma G, Mirandola P, Menotti L. Human herpesvirus 6: an emerging pathogen. Emerg Infect Dis 1999; 5: 353.
2. Humar A, Kumar D, Caliendo AM, et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 2002; 73(4): 599.
3. Okuno T, Takahashi K, Balachandra K, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989; 27: 651.
4. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352: 768.
5. Singh N, Donald C, Timothy G, Marino I. Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997; 64: 674.
6. Benito N, Ricart MJ, Pumarola T, et al. Infection with human herpesvirus 6 after kidney-pancreas transplant. Am J Transplant 2004; 4(7): 1197.
7. Singh N, Paterson DL. Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 2000; 69: 2474-2479
8. Rossi C, Delforge ML, Jacobs F, et al. Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation 2001; 71: 288.
9. Humar A, Malkan G, Moussa G, et al. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 2000; 181: 1450.
10. DesJardin J, Cho E, Supran S, et al. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. Clin Infect Dis 2001; 33: 1358.
11. Dockrell DH, Prada J, Jones MF, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997; 176: 1135.
12. Benito N, Moreno A, Pumarola T, Marcos MA. Human herpesvirus type 6 and type 7 in transplant recipients. Enferm Infecc Microbiol Clin 2003; 21: 424.
13. Humar A, Payá C, Pescovitz MD, et al. Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients. Am J Transplant 2004; 4(4): 644.
14. Razonable RR, Brown RA, Humar A, et al. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 2005; 192: 1331.